On World Rare Diseases Day, read on to learn more about Myasthenia Gravis, a complex autoimmune disorder that requires ...

Paediatric MuSK myasthenia gravis is exceedingly rare and is typically managed with pyridostigmine, corticosteroids and intravenous immunoglobulin or plasmapheresis for acute crisis control. This ...

Decreased AChR-Ab titers correlated with improved myasthenia gravis symptoms, especially in ADL scores, within the first 3 months of treatment. The study found no baseline correlation between AChR ...

Myasthenia gravis (MG) is an autoimmune disease primarily mediated by acetylcholine receptor ... The patient deteriorated to a myasthenic crisis, and high doses of immunoglobulin, corticosteroids, ...

THE occurrence of thyrotoxicosis in patients with myasthenia gravis is not rare, over 90 such cases having been reported since the turn of the century. 1,2 Various estimates place the incidence of ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor ...